Helius Therapeutics has partnered with pharmaceutical company Balancial Denmark. This marks the debut of these New Zealand-grown and made products in the Danish market.
Carmen Doran, CEO of Helius Therapeutics, commented, "Our partnership with Balancial Denmark is a significant milestone in our mission to broaden access to high-quality medicinal cannabis. We are confident that our New Zealand-grown extracts will meet the high standards expected in the Danish market and positively impact patient care."
Bo Tandrup, Managing Director of Balancial Denmark, added, "We are delighted to collaborate with Helius Therapeutics to introduce their medicinal cannabis extracts to Denmark. This partnership underscores our dedication to providing advanced treatment solutions while adhering to the highest regulatory standards."
As part of the partnership, both companies are committed to delivering educational support to healthcare professionals. This includes providing detailed product information, best practices for patient management, and ongoing training to ensure the effective integration of medicinal cannabis into treatment plans. The goal is to equip healthcare providers with the knowledge and resources necessary to offer informed guidance and optimize patient outcomes.
For more information:
Helius
www.helius.co.nz